science

HIV-associated lipodystrophy

HIV-associated lipodystrophy is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand HIV-associated lipodystrophy rather than just read about it. In short: HIV-associated lipodystrophy is a condition characterized by loss of subcutaneous fat associated with infection with HIV. Presentation HIV-associated lipodystrophy commonly presents with fat loss in face, buttocks, arms and legs.

Key takeaways

HIV-associated lipodystrophy belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect HIV-associated lipodystrophy to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of HIV-associated lipodystrophy from memory before moving on to harder problems.

Reference excerpt

HIV-associated lipodystrophy is a condition characterized by loss of subcutaneous fat associated with infection with HIV.

Presentation HIV-associated lipodystrophy commonly presents with fat loss in face, buttocks, arms and legs. There is also fat accumulation in various body parts. Patients often present with "buffalo hump"-like fat deposits in their upper backs. Breast size of patients (both male and female) tends to increase. In addition, patients develop abdominal obesity.

Cause The exact mechanism of HIV-associated lipodystrophy is not fully elucidated. There is evidence indicating both that it can be caused by anti-retroviral medications and that it can be caused by HIV infection in the absence of anti-retroviral medication.

Evidence implicating anti-retroviral medications

The development of lipoatrophy in people living with HIV has been historically linked to specific classes of early antiretroviral therapy (ART). Initial treatment regimens typically combined a protease inhibitor (PI) with two nucleoside reverse transcriptase inhibitors (NRTIs), specifically thymidine analogs like stavudine (d4T) and zidovudine (AZT). While these drugs helped maintain CD4 T-cell levels, they were strongly associated with changes in lipid metabolism and significant subcutaneous fat loss, often resulting in a 30% reduction of fat in the extremities and noticeable facial wasting. Other older drugs, such as the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz, have also been implicated in fat loss. The incidence of the condition dropped dramatically following the transition to newer, less toxic medications. By the late 2000s, clinical guidelines recommended replacing zidovudine with tenofovir disoproxil fumarate (TDF), which exhibited significantly lower lipoatrophic effects. This was further improved by the introduction of tenofovir alafenamide (TAF), which is largely devoid of lipodystrophy.

Evidence implicating HIV infection alone On the other hand, there is evidence that HIV-1 infection on its own contributes to the development of the lipodystrophic phenotype by interfering with some key genes of adipocyte differentiation and mitochondrial function on patients which have not received antiretroviral treatment.

Management Injectable fillers, including the calcium hydroxylapatite-based Radiesse and poly-L-lactic acid-based Sculptra, are indicated to restore volume lost due to HIV-associated facial lipoatrophy. GHRH analogs such as tesamorelin can be used to treat HIV-associated lipodystrophy.

Prognosis Reversion of lipodystrophy does not occur after withdrawal of protease inhibitors.

See also Drug-induced lipodystrophy Lipodystrophy List of cutaneous conditions

References

External links

Worked examples

Example 1 — a first encounter with HIV-associated lipodystrophy

Start with the simplest possible case. Write down what HIV-associated lipodystrophy claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to HIV-associated lipodystrophy before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about HIV-associated lipodystrophy ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of HIV-associated lipodystrophy

In research: HIV-associated lipodystrophy appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses HIV-associated lipodystrophy in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: HIV-associated lipodystrophy is common in secondary-school and first-year university syllabi. It links to neighbouring topics Conditions of the subcutaneous fat, HIV/AIDS, so understanding it makes those chapters shorter.
In everyday life: Look for HIV-associated lipodystrophy outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “HIV-associated lipodystrophy” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study HIV-associated lipodystrophy in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what HIV-associated lipodystrophy means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain HIV-associated lipodystrophy out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is HIV-associated lipodystrophy in simple terms?

HIV-associated lipodystrophy is a condition characterized by loss of subcutaneous fat associated with infection with HIV. Presentation HIV-associated lipodystrophy commonly presents with fat loss in face, buttocks, arms and legs.

Why does HIV-associated lipodystrophy matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study HIV-associated lipodystrophy?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on HIV-associated lipodystrophy.